In a near-simultaneously published study, Dias and colleagues detected considerable amounts of GLS2 protein in 14 triple-negative (TN) breast cancer cell lines, which included basal, luminal, and mesenchymal subtypes, while a significantly lower content of GLS2 was found in four non-TN cell lines [79]. This evidence concerns the gene GLS2 and breast carcinoma.